SE Stockholm Larsson NG: Difference between revisions

From Bioblast
No edit summary
No edit summary
Line 1: Line 1:
{{MiPNetLab
{{MiPNetLab
|address=Larsson Nils-GΓΆran
|address=Larsson Nils-GΓΆran, Prof. Dr.


Division of Metabolic Diseases, Department of Laboratory Medicine, Β 
Division of Metabolic Diseases, Department of Laboratory Medicine, Β 
Line 10: Line 10:
|country=Germany
|country=Germany
|MiPNetLab=Larsson NG, Looman C, Mourier A, Schmitz L
|MiPNetLab=Larsson NG, Looman C, Mourier A, Schmitz L
|Team previous=Franko A,
|Team previous=Franko A
|info=[http://oroboros.at/index.php?id=ioc53 IOC53], [http://www.oroboros.at/index.php?id=ioc68 IOC68]
|info=[http://www.oroboros.at/?IOC68 IOC68], [http://oroboros.at/?IOC53 IOC53]
|Info=[http://www.oroboros.at/index.php?id=1220 DE_Cologne_LarssonNG]
|Info=[http://www.oroboros.at/index.php?id=1220 DE_Cologne_LarssonNG]
}}
}}

Revision as of 14:08, 19 April 2012

Cookies help us deliver our services. By using our services, you agree to our use of cookies.